Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.

Narayan, Rupa

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 07 2019 - 1293-1303 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

1523-6536

10.1016/j.bbmt.2019.03.027 doi


Adult
Aged
Allografts
Cytokine-Induced Killer Cells--transplantation
Disease-Free Survival
Female
Hematologic Neoplasms--mortality
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Myeloproliferative Disorders--mortality
Survival Rate
Tissue Donors